Evidence map›Paper›PMID 34466195›Full record

ArticleThe Pan African medical journal2021

Digital technologies and COVID-19: reconsidering lockdown exit strategies for Africa.

Itai Chitungo, Malizgani Mhango, Elliot Mbunge, Mathias Dzobo, Tafadzwa Dzinamarira

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Itai ChitungoDepartment of Laboratory Diagnostics and Investigative Science, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Malizgani MhangoSchool of Public Health, University of Western Cape, 7535, Cape Town, South Africa.
Elliot MbungeDepartment of Information Technology, Faculty of Accounting and Informatics, Durban University of Technology, P O Box 1334, Durban 4000, South Africa.
Mathias DzoboDepartment of Laboratory Diagnostics and Investigative Science, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Tafadzwa DzinamariraICAP at Columbia University, Kigali, Rwanda.
Carnegie Mellon University Africa · RWDurban University of Technology · ZAUniversity of the Western Cape · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Widespread vaccination provides a means for countries to lift strict COVID-19 restrictions previously imposed to contain the spread of the disease. However, to date, Africa has secured enough COVID-19 vaccine doses for less than 5% of its population. With widespread vaccination not on the horizon for Africa, there is a strong emphasis on non-pharmaceutical interventions which include movement restrictions (lockdowns). This general COVID-19 pandemic response of imposing lockdowns, however, neglects to factor in non-fatal consequences leading to disruption socio-economic wellbeing of the society at large. The economy in most African countries can no longer sustain lockdown restrictions. Some studies have indicated that a hard lockdown statistical value of the extra lives saved would be dwarfed by its long-term cost. At the same time not responding to the threat of the pandemic will cost lives and disrupts the social fabric. This paper proffers ways to mitigate the both and advocate for better policymaking that addresses specific challenges in defined communities thus yield higher population welfare.

Indexed as

Digital TechnologyHealth PolicyAfricaCOVID-19COVID-19 VaccinesHumansPolicy MakingQuarantineSocioeconomic FactorsVaccinationCOVID-19 VaccinesAfricaCOVID-19lockdown

Identifiers

PMID34466195
PMCPMC8379416
OpenAlexW3169130506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.